APIMEDS PHARMACEUTICALS US I
APUS·03771D102·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic-Activist
APUS (APIMEDS PHARMACEUTICALS US I) is held by 5 institutional investors as of Q2 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($57,289), GEODE CAPITAL MANAGEMENT, LLC ($31,602), VANGUARD FIDUCIARY TRUST CO ($21,635). Net institutional sentiment: Mixed.
5
Holders
$135,555
Total Value
50% (4)
Consensus
2 buying - 2 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Aug 28, 2026 · Insiders May 15, 2025 · Activists May 7, 2026 · Congress none
ActivistINInscobee Inc.16.7%May 7, 2026
ActivistAYAyrton Capital LLC10.0%Feb 11, 2026
InsiderKCKim ChristopherBuy $14KMay 14, 2025
Checking access…
Top Holders
Checking access…
Continue exploring
Other Healthcare stocks held by institutions
403 holders · $856.6B
403 holders · $286.8B
388 holders · $148B
385 holders · $405.5B
384 holders · $95B
381 holders · $105.8B
378 holders · $226B
375 holders · $51.2B
373 holders · $296.3B
371 holders · $110.7B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer